金吾财讯 | 吉利德科学(GILD)公布2024年第四季财报。期内，纯利按年升25%至17.83亿美元，每股季度摊薄纯利1.42美元，经调整后为1.9美元，高于市场预期的1.7美元。期内，集团收入按年升6%至75.69亿美元，高于市场预期的71.4美元。其中爱滋病药销售按年升16%至55亿美元。指引方面，公司预计今年销售介乎282亿至286亿美元，市场预期为284.2亿美元。公司亦预计今年经调整每股盈利7.7至8.1美元，市场预期为7.58美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.